These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7254682)
1. Platelet-activating factor (PAF), a mediator of platelet aggregation. Effect of corticosteroids on PAF-induced platelet aggregation. Camussi G; Bussolino F; Tetta C; Deregibus MC; Segoloni G; Ragni R; Vercellone A Minerva Nefrol; 1980; 27(4):589-92. PubMed ID: 7254682 [No Abstract] [Full Text] [Related]
2. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056 [No Abstract] [Full Text] [Related]
3. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Cazenave JP; Benveniste J; Mustard JF Lab Invest; 1979 Sep; 41(3):275-85. PubMed ID: 112332 [No Abstract] [Full Text] [Related]
4. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives. Keraly CL; Benveniste J Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588 [TBL] [Abstract][Full Text] [Related]
5. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. Romero A; Muniain MA; Mata R; Pozuelo F; Pérez JJ; Rodríguez MC; Rodríguez MD Rev Esp Fisiol; 1988 Dec; 44(4):407-12. PubMed ID: 3072620 [TBL] [Abstract][Full Text] [Related]
6. Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs. Demopoulos CA; Tsabikakis GE; Kapoulas VM Immunol Lett; 1981 Aug; 3(3):133-5. PubMed ID: 7287060 [TBL] [Abstract][Full Text] [Related]
7. [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. Benveniste J; Tencé M; Varenne P; Bidault J; Boullet C; Polonsky J C R Seances Acad Sci D; 1979 Nov; 289(14):1037-40. PubMed ID: 121258 [TBL] [Abstract][Full Text] [Related]
8. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation. Zhang M; Zhang LZ; Lu JS Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812 [TBL] [Abstract][Full Text] [Related]
9. [Platelet aggregation and platelet activating factor (author's transl)]. Chignard M; Vargaftig BB; Benveniste J; Le Couedic JP J Pharmacol; 1980; 11(4):371-7. PubMed ID: 7206730 [TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205 [TBL] [Abstract][Full Text] [Related]
11. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation. Bussolino F; Camussi G Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196 [TBL] [Abstract][Full Text] [Related]
12. Evidence for the production of platelet-activating factor by murine embryos and its putative role in the maternal physiology. Suzuki H; Taguchi Y; Kojima T; Nishihira J; Kanagawa H Biochem Mol Biol Int; 1995 Nov; 37(4):617-26. PubMed ID: 8589634 [TBL] [Abstract][Full Text] [Related]
13. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. Yi FX; Guo ZG Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889 [TBL] [Abstract][Full Text] [Related]
15. Aspects of PAF (platelet activating factor)-induced aggregation by using rabbit platelets. Isobe J; Mizuno A Tokushima J Exp Med; 1982 Dec; 29(3-4):143-9. PubMed ID: 7170716 [No Abstract] [Full Text] [Related]
16. An anti-platelet activating factor antibody and its effects on platelet aggregation. Tatsumi N; Terano Y; Hashimoto K; Hiyoshi M; Matsuura S Osaka City Med J; 1993 Nov; 39(2):167-74. PubMed ID: 8183536 [TBL] [Abstract][Full Text] [Related]
17. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions. Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity. Castro-Faria-Neto HC; Martins MA; Silva PM; Bozza PT; Cruz HN; de Queiroz-Paulo M; Kaplan MA; Cordeiro RS J Lipid Mediat; 1993 May; 7(1):1-9. PubMed ID: 8358020 [TBL] [Abstract][Full Text] [Related]
19. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine. Zeng S; Guo ZG Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970 [TBL] [Abstract][Full Text] [Related]
20. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI; Muzya GI Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]